Research Article
Prevalence of E. coli ST131 among Uropathogenic E. coli Isolates from Iraqi Patients in Wasit Province, Iraq
Table 6
Antimicrobial resistance of 17 E. coli ST131 isolates.
| Class of antimicrobial agent | Antimicrobial agent | No. (%) of resistant E. coli ST131 isolates |
| β-Lactams | AMP | 17 (100): R = 17, I = 0 | AMC | 15 (88.2): R = 12, I = 3 | FOX | 13 (76.4): R = 7, I = 6 | CTX | 12 (70.5): R = 10, I = 2 | CAZ | 13 (76.4): R = 10, I = 3 | CRO | 9 (52.9): R = 9, I = 0 | FEP | 14 (82.3): R = 9, I = 5 | ATM | 10 (58.8): R = 7, I = 3 | IPM | 0 | MEM | 0 | Aminoglycosides | CN | 3 (17.6): R = 2, I = 1 | AK | 1 (5.8): R = 0, I = 1 | Tetracyclines | TE | 13 (76.4): R = 10, I = 3 | Fluoroquinolone | NA | 7 (41.1): R = 7, I = 0 | CIP | 6 (35.2): R = 5, I = 1 | Trimethoprim | SXT | 8 (47.0): R = 8, I = 0 | Nitrofurans | F | 1 (5.8): R = 1, I = 0 | Multidrug resistance (MDR) | 9 (52.9) |
|
|
R: resistant; I: intermediate.
|